| Pharmaceutical active ingredients: |
| Rifaximin |
| Available forms, composition and doses of Lumenax: |
| N / A |
| Lumenax medical category: |
| Human:Antibiotics (semisynthetic rifamycin-based non-systemic) |
| Indications and usages, anatomical therapeutic chemical and diseases classification codes: |
| A07AA11 - Rifaximin |
| Pharmaceutical companies: manufacturers, researchers, developers, local distributors and suppliers: |
| Unidentified Pharmaceutical Company |
| Trade name |
Active ingredients |
Pharmaceutical company |
|
Lulamin | Thalidomide | Unidentified Pharmaceutical Company |
| Lumbeck | Nortriptyline | Unidentified Pharmaceutical Company |
| Lumbrical | Piperazine | Unidentified Pharmaceutical Company |
| Lumen | Phenobarbital | Unidentified Pharmaceutical Company |
| Lumenac | N-Acetylcysteine | Unidentified Pharmaceutical Company |
| Lumesettes | Phenobarbital | Unidentified Pharmaceutical Company |
| Lumesyn | Phenobarbital | Unidentified Pharmaceutical Company |
| Lumofridetten | Phenobarbital | Unidentified Pharmaceutical Company |
| Lumolinine | Invert Sugar | Unidentified Pharmaceutical Company |
| Lumopaque | Tyropanoate | Unidentified Pharmaceutical Company |